GYNECOLOGIC CANCER

Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20.Read more....

Related Posts

DEVELOPMENTAL THERAPEUTICS—IMMUNOTHERAPY

 73

Single-molecule covalent magnetic tweezers

 29

GENITOURINARY CANCER—KIDNEY AND BLADDER

 27